Metabolic downregulation: a key to successful neuroprotection? - Wikidata - awgldk - TriplyDB

Metabolic downregulation: a key to successful neuroprotection?

Metabolic downregulation: a key to successful neuroprotection?

http://www.wikidata.org/entity/Q37227909

about

Neuroprotection for stroke: current status and future perspectives Stem cell therapy for neonatal hypoxic-ischemic encephalopathy Neurovascular effects of CD47 signaling: promotion of cell death, inflammation, and suppression of angiogenesis in brain endothelial cells in vitro Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway Tetramethylpyrazine nitrone, a multifunctional neuroprotective agent for ischemic stroke therapy.In cold blood: intraarteral cold infusions for selective brain cooling in stroke Neuroprotective effects of ischemic preconditioning on global brain ischemia through up-regulation of acid-sensing ion channel 2a Pharmaco-proteomics opportunities for individualizing neurovascular treatment.Social interaction modulates autonomic, inflammatory, and depressive-like responses to cardiac arrest and cardiopulmonary resuscitation 3-Nitropropionic acid-induced ischemia tolerance in the rat brain is mediated by reduced metabolic activity and cerebral blood flow Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials?Combination treatment of hypothermia and mesenchymal stromal cells amplifies neuroprotection in primary rat neurons exposed to hypoxic-ischemic-like injury in vitro: role of the opioid system.Hypothermia protects human neurons.Mild hypothermia combined with neural stem cell transplantation for hypoxic-ischemic encephalopathy: neuroprotective effects of combined therapy.Decreased extracellular adenosine levels lead to loss of hypoxia-induced neuroprotection after repeated episodes of exposure to hypoxia.Global SUMOylation is a molecular mechanism underlying hypothermia-induced ischemic tolerance Towards a dynamical network view of brain ischemia and reperfusion. Part I: background and preliminaries.Therapeutic hypothermia after cardiac arrest: experience at an academically affiliated community-based veterans affairs medical center.Hypothermia augments neuroprotective activity of mesenchymal stem cells for neonatal hypoxic-ischemic encephalopathy.Investigational therapies for ischemic stroke: neuroprotection and neurorecovery.Preconditioning induces sustained neuroprotection by downregulation of adenosine 5'-monophosphate-activated protein kinase.Neuroprotection: lessons from hibernators.Hypothermia during Carotid Endarterectomy: A Safety Study A Head and Neck Support Device for Inducing Local Hypothermia.ADVANCES IN THE CELL-BASED TREATMENT OF NEONATAL HYPOXIC-ISCHEMIC BRAIN INJURY Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.Biological networks in ischemic tolerance - rethinking the approach to clinical conditioning When hypothermia meets hypotension and hyperglycemia: the diverse effects of adenosine 5'-monophosphate on cerebral ischemia in rats.Hypoxic preconditioning-induced cerebral ischemic tolerance: role of microvascular sphingosine kinase 2.Limitations of Mild, Moderate, and Profound Hypothermia in Protecting Developing Hippocampal Neurons After Simulated Ischemia.Advancing critical care medicine with stem cell therapy and hypothermia for cerebral palsy.Ischemic tolerance in stroke treatment Use of hypothermia in the intensive care unit.New approaches to neuroprotection in infant heart surgery.Induced hypothermia for trauma: current research and practice.Therapeutic hypothermia for brain ischemia: where have we come and where do we go?Pediatric stroke.Ischemic tolerance in the brain: endogenous adaptive machinery against ischemic stress.Neuroprotection for ischaemic stroke: translation from the bench to the bedside.Improving neurological outcome after cardiac arrest: Therapeutic hypothermia the best treatment.

P2860

Q26853031-70815B89-B01D-492A-8B2B-CC3A19891E4D Q27003906-F7443EF0-309F-4C5E-A15B-03D3C8090E75 Q28240979-A9F7088E-4F08-467A-9D98-9EB364598E41 Q28570824-00DC50B8-EE1A-4A9A-9B32-87BBACC171F9 Q30828492-7937C3B7-F6C3-45DC-9799-213681BFE87C Q33581184-F57BE8B2-3F72-451F-8FBA-77EF225D8818 Q33649207-9E2C0585-4DD6-433A-81E5-B8D188D74476 Q34128934-E155081C-BADF-4B19-85B8-3CE1C8FA9D54 Q34136560-9F039964-9E22-4C0E-9235-38B28E33B879 Q34153446-84A5CBE4-A2FF-413D-826F-3664BDCA1082 Q34171143-ABC6221D-E012-45CD-BB6C-241136448263 Q34450985-7B581FD6-D86F-43DE-B86E-C7CA3CF251C2 Q34531612-641BA45C-17FF-4F59-B202-7D30C1FA1832 Q34546178-BFF3693D-4C58-4000-B1BF-C6AB70D253D8 Q34599971-9F3C6471-0A76-4C66-9FA7-081332DBA869 Q34630903-E6E7B2A3-0F59-45E0-99D3-9EC4C1B60CC2 Q34854026-97C7FF3E-44B1-4EF6-8F42-232776844394 Q35117242-3FC8F09C-A58F-4751-9DC6-02E27B8D30E6 Q35224866-97898B76-57ED-4ADB-B0A3-C7CB19A5A18D Q35648103-35DC9093-5ABC-4B94-977C-283F53FA9079 Q35672764-67169388-83E0-4886-9337-303A10D93127 Q35907297-19B02CD9-E0F0-46DB-AD3D-5DBE2504B45B Q35983841-AE6D1BBC-E1F5-4C30-9043-630B26BD98BF Q36401099-73DDAC34-8F4A-4280-9DC8-46BC2989CB52 Q36737627-3DD643E6-3302-449A-8798-FA84AAD8B34B Q37158226-CE695140-B501-454C-9E1A-1E2DD10EDFFD Q37291743-5C37456A-4158-450D-A79D-804325E19AB6 Q37304516-2122D648-7589-4CD0-BFBB-4321E78B7F7B Q37366651-ED852897-A93E-41EB-81E5-B4E22889F66F Q37404036-A56B8C24-87D0-4E41-A432-B021281CCDF7 Q37470229-A3839685-37DE-43C0-8E77-7BFE9BC0071F Q37611049-46229C76-EC73-41DF-8FA4-9F811CCC0961 Q37636646-28C115FF-4D98-4489-85AC-E9A07854BD2E Q37721125-AEC70E32-B7C1-496E-BECD-03127B5372B1 Q37742952-83FC8780-7692-48A3-867B-BF6E8B9651BA Q37793691-1E9C55C0-0AA7-4DC0-A547-E8F05E02D38A Q37845247-88CDA2DC-1475-4780-BA97-7F30099A23B4 Q37981130-ECE31B2B-E2D7-479D-8801-DDF39EEB2F4D Q37991061-E0B46C24-8275-48C6-87F0-2C73E9CD51D8 Q38426188-E94DF92D-2864-431A-B241-2094E8AED6B7

P2860

Metabolic downregulation: a key to successful neuroprotection?

http://www.wikidata.org/entity/Q37227909

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 July 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Metabolic downregulation: a key to successful neuroprotection?

@en

Metabolic downregulation: a key to successful neuroprotection?

@nl

type

label

Metabolic downregulation: a key to successful neuroprotection?

@en

Metabolic downregulation: a key to successful neuroprotection?

@nl

prefLabel

Metabolic downregulation: a key to successful neuroprotection?

@en

Metabolic downregulation: a key to successful neuroprotection?

@nl

P1433

Q37227909-AF10B524-69A8-4EC2-8628-8E178E8715CD

P1476

Q37227909-2B07B3C1-7A82-42E1-9DBB-0E3BBFEFF47D

P2093

Q37227909-A8BBF663-9AEF-452D-8D06-1049CB697C5C

Q37227909-B8132318-EF46-41CE-A000-14BA0E85D639

Q37227909-D2F6D88B-6ED7-4617-AC61-219FB94AB547

Q37227909-D8E8A526-577D-4DD1-AED9-9199374710AB

P2860

Q37227909-03EFCF81-FB09-42D1-96CC-1DD213668D73

Q37227909-06994EC0-948C-4EAC-BBE0-8A92A88BA928

Q37227909-08775EF5-7673-4604-A356-A279DB9EC3E2

Q37227909-095DC848-1BFF-4632-85B4-D142057DE062

Q37227909-0BB32288-CA4C-4FD4-B817-704EDB65A310

Q37227909-0C6D7FB2-DF10-45F1-99BB-A76101F80687

Q37227909-128091D4-74CF-4CD6-ABFA-761DEE16B381

Q37227909-12FABC1B-2913-4AF2-921D-B89CC4561229

Q37227909-146778EA-5C35-4732-BD6A-67D784D7D44B

Q37227909-1A467DD9-7221-4F2C-83B9-B87151544791

P304

Q37227909-708CE965-BFCF-4C02-B141-73BE8CAD3412

P31

Q37227909-C5B1A117-886C-48D2-BF87-0B729ABCB2B2

P356

Q37227909-78909310-BD71-4284-952D-82667A4180EE

P407

Q37227909-919FAD27-D985-48B4-92BF-0327BEA8485A

P433

Q37227909-2F44C323-908E-4456-8AE0-DB6E3CFA2257

P478

Q37227909-CC841A42-8549-40E6-83AE-20F4A90D117F

P577

Q37227909-87033D48-CF48-46B5-8B0D-FA65AEFD71C9

P698

Q37227909-986CF86D-BEEF-45F2-9BEE-C0AD0A8A0567

P932

Q37227909-4312FE68-690B-4302-9DC6-728DE5AAB65B

P356

STROKEAHA.108.514471

P1433

P1476

Metabolic downregulation: a key to successful neuroprotection?

@en

P2093

Kazuo Kitagawa

http://www.w3.org/2001/XMLSchema#string

Midori Yenari

http://www.w3.org/2001/XMLSchema#string

Miguel Perez-Pinzon

http://www.w3.org/2001/XMLSchema#string

Patrick Lyden

http://www.w3.org/2001/XMLSchema#string

P2860

Primary prevention of ischemic stroke

Neurotensin-induced hypothermia improves neurologic outcome after hypoxic-ischemia

3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone

Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model

Preconditioning with cortical spreading depression decreases intraischemic cerebral glutamate levels and down-regulates excitatory amino acid transporters EAAT1 and EAAT2 from rat cerebal cortex plasma membranes

Effect of peroxide, sodium, and calcium on brain mitochondrial respiration in vitro: potential role in cerebral ischemia and reperfusion

Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia

Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest

Ischemic tolerance in the rat neocortex following hypothermic preconditioning.

Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1.

P304

2910-2917

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/STROKEAHA.108.514471

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18658035

http://www.w3.org/2001/XMLSchema#string

P932

2597567

http://www.w3.org/2001/XMLSchema#string